AzTrials
AzTrials

Suicidal IdeationCARESNCT06689657

Understanding and Acting to Regulate Suicidal Behavior

A study testing Cognitive behavioral group therapy for adolescents and non violent resistance group for parents and Adolescent group therapy (CARES) and parent group therapy (RNV) in people with Suicidal Ideation and Suicidal Behavior, run by University Hospital, Montpellier.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Data from Santé Publique France show that since the onset of the health crisis (covid-19), there has been an increase in emergency room visits for mood disorders among children under 15 years of age, with a notable rise in the number of visits since early September 2020 compared to previous years. Read more about this study

Who is it for?
Ages 12 to 16 years
What is being tested?
Cognitive behavioral group therapy for adolescents and non violent resistance group for parents and Adolescent group therapy (CARES) and parent group therapy (RNV)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
No sites listed yet
Study dates
6 Jan 2025to 6 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age from 12 to 16 years 11 months old
  • Active suicidal ideation and/or suicidal behavior during the last 6 months
  • The patient is referred by a healthcare professional

Who cannot join

  • Intellectual developmental disorder
  • Non-french speaking
  • Planned travel not allowing the complete following of the study
  • The patient, the parents or the legal guardian can not be correctly informed
  • The patient presents symptoms that prevent him from group interaction (behavior disorders, hallucinations, delirium)
  • The family already followed the same kind of program
Show all 10Show fewer
  • The patient is already enrolled in a clinical trial or is taking a treatment off full market approval during 4 weeks before screening
  • The patient and the family are not affiliated to any healthcare insurance
  • No signed consent from parents or a legual guardian nor one of the parental authority holder
  • The patient did not consent

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Randomized Study of Two Modalities of Cognitive-behavioral Group Therapy in Adolescents with Suicidal Ideation or Suicidal Behavior

Data from Santé Publique France show that since the onset of the health crisis (covid-19), there has been an increase in emergency room visits for mood disorders among children under 15 years of age, with a notable rise in the number of visits since early September 2020 compared to previous years. Recent literature considers Dialectical Behavior Therapy (DBT) as the only approach that has demonstrated (albeit weak to moderate) effects on the recurrence of self-harming behaviors. It is within this context, and based on these various findings, that the CARES program was developed (Understanding and Acting to Regulate Emotions and Suicidal Behaviors), aimed at adolescents who have engaged in suicidal behaviors or who have active suicidal ideation.

The objective of this study is to compare the CARES program for adolescents alone to the CARES program for adolescents combined with a parent group using Non-Violent Resistance (NVR) on the occurrence of self-harming behaviors among adolescents who have engaged in suicidal acts and/or have active suicidal ideation, six months after the conclusion of the intervention.

This is a prospective, randomized, open-label, single-center, controlled study with two parallel arms, with blinded assessment of the outcome measures.

Read the detailed description

The CARES adolescent program consists of a group intervention with 8 biweekly sessions over a total duration of one month, followed by a booster session 3 months post-intervention. These sessions are conducted by nurses and psychologists trained in Cognitive Behavioral Therapies (CBT). The content of the group aims to provide adolescents with cognitive and behavioral strategies to improve their emotional distress tolerance and to expand their repertoire of solutions in times of emotional crisis.

The CARES adolescent and NVR parent program includes the same adolescent group described above, supplemented by an NVR parent group. This parent group meets once a week for one month (4 sessions), with two additional booster sessions at 1 month and 3 months post-intervention. The content of the parent program is a parent management training composed of strategies for managing their adolescent's emotional crises through emotional regulation techniques based on Non-Violent Resistance (NVR) methods (Omer, 2021).

Being tested
Cognitive behavioral group therapy for adolescents and non violent resistance group for parents, Adolescent group therapy (CARES) and parent group therapy (RNV)
Keywords
Suicide prevention, Cognitive-behavioral therapy, Dialectical Behavior Therapy, Non pharmacological intervention, Adolescent
Medical subject headings
Suicidal Ideation, Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioral group therapy for adolescents and non violent resistance group for parentsBehavioural

    In the adolescents group, this cognitive-behavioral group therapy will include emotion regulation skills, distress tolerance skills, cognitive strategies, work on values and problem-solving strategies

    Those sessions will include psychoeducation about adolescents, about suicidal ideation and suicidal behavior, coping with adolescent emotional distress, support on how to be a parent today (screen regulation...) and manage daily life

  • Adolescent group therapy (CARES) and parent group therapy (RNV)Other

    In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment

Study groups in NCT06689657
Study groupRoleWhat they receive
Adolescent group therapy (CARES) and parent group therapy (RNV)OtherIn the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment
Receives: Other: Adolescent group therapy (CARES) and parent group therapy (RNV)
Adolescent groupe therapy (CARES) onlyExperimentalIn the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There will be a "boost" session 3 month after the last session Patients will be randomized in each group with blinded assessment
Receives: Behavioral: Cognitive behavioral group therapy for adolescents and non violent resistance group for parents

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurence of suicidal behavior

    Assessed with the Columbia Suicide Severity Rating Scale (C-SSRS)

    Measured: Variation between initial assessment and assessment 6 month post intervention

Secondary outcomes (5)
  1. Clinical improvement assessement (clinician)

    Assessment with the Clinical Global Impression-Improvement (CGI-I)

    Measured: Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  2. Parenting stress

    Assessment with the Parenting Stress Index short form (PSI-4-SF)

    Measured: Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  3. Parenting anxiety and depression

    Assessment with the Hospital Anxiety and Depression Scale (HADS)

    Measured: Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  4. Adolescent depression

    Assessment with the Child Depression Inventory (CDI)

    Measured: Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  5. Suicidal ideation

    Assessment with the C-SSRS

    Measured: Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2024
  2. Study start6 Jan 2025 (estimated)
  3. Primary completion6 Jan 2028 (estimated)
  4. Study completion6 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Adolescent group therapy (CARES) and parent group therapy (RNV) vs Adolescent groupe therapy (CARES) only
Masking
Single blind
Who is masked
Participant
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06689657
Sponsor's protocol ID
RECHMPL22_0339 / UF 8379
Acronym
CARES
Status last verified
Nov 2024
First submitted
13 Nov 2024
Last updated
14 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive behavioral group therapy for adolescents and non violent resistance group for parents and Adolescent group therapy (CARES) and parent group therapy (RNV) in people with Suicidal Ideation and Suicidal Behavior, run by University Hospital, Montpellier.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 14 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Julie CABROL (0467337196 ext. +33, cares@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurence of suicidal behavior (time frame: Variation between initial assessment and assessment 6 month post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in